A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles

por Rodrigues Sousa, Elisa, Zoni, Eugenio, Karkampouna, Sofia, La Manna, Federico, Gray, Peter C., De Menna, Marta, Kruithof-de Julio, Marianna
Publicado 2020

FOXE1-Dependent Regulation of Macrophage Chemotaxis by Thyroid Cells In Vitro and In Vivo

por Credendino, Sara C., De Menna, Marta, Cantone, Irene, Moccia, Carmen, Esposito, Matteo, Di Guida, Luigi, De Felice, Mario, Vita, Gabriella De
Publicado 2021

PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells

por Vitiello, Michela, Valentino, Teresa, De Menna, Marta, Crescenzi, Elvira, Francesca, Paola, Rea, Domenica, Arra, Claudio, Fusco, Alfredo, De Vita, Gabriella, Cerchia, Laura, Fedele, Monica
Publicado 2016

Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial

por Seiler, Roland, Egger, Martin, De Menna, Marta, Wehrli, Saskia, Minoli, Martina, Radić, Martina, Lyatoshinsky, Pavel, Hösli, Raphael, Blarer, Jennifer, Abt, Dominik, Kruithof-de Julio, Marianna
Publicado 2023

Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity

por La Manna, Federico, De Menna, Marta, Patel, Nikhil, Karkampouna, Sofia, De Filippo, Maria Rosaria, Klima, Irena, Kloen, Peter, Beimers, Lijkele, Thalmann, George N., Pelger, Rob C. M., Jacinto, Estela, Kruithof-de Julio, Marianna
Publicado 2020

Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity

por La Manna, Federico, De Menna, Marta, Patel, Nikhil, Karkampouna, Sofia, De Filippo, Maria Rosaria, Klima, Irena, Kloen, Peter, Beimers, Lijkele, Thalmann, George N., Pelger, Rob C. M., Jacinto, Estela, Kruithof-de Julio, Marianna
Publicado 2021

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection

por Laise, Pasquale, Stanifer, Megan L., Bosker, Gideon, Sun, Xiaoyun, Triana, Sergio, Doldan, Patricio, La Manna, Federico, De Menna, Marta, Realubit, Ronald B., Pampou, Sergey, Karan, Charles, Alexandrov, Theodore, Kruithof-de Julio, Marianna, Califano, Andrea, Boulant, Steeve, Alvarez, Mariano J.
Publicado 2022

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection

por Laise, Pasquale, Stanifer, Megan L., Bosker, Gideon, Sun, Xiaoyun, Triana, Sergio, Doldan, Patricio, La Manna, Federico, De Menna, Marta, Realubit, Ronald B., Pampou, Sergey, Karan, Charles, Alexandrov, Theodore, Kruithof-de Julio, Marianna, Califano, Andrea, Boulant, Steeve, Alvarez, Mariano J.
Publicado 2022

Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy

por Hirt, Christian K., Booij, Tijmen H., Grob, Linda, Simmler, Patrik, Toussaint, Nora C., Keller, David, Taube, Doreen, Ludwig, Vanessa, Goryachkin, Alexander, Pauli, Chantal, Lenggenhager, Daniela, Stekhoven, Daniel J., Stirnimann, Christian U., Endhardt, Katharina, Ringnalda, Femke, Villiger, Lukas, Siebenhüner, Alexander, Karkampouna, Sofia, De Menna, Marta, Beshay, Janette, Klett, Hagen, Kruithof-de Julio, Marianna, Schüler, Julia, Schwank, Gerald
Publicado 2022

Patient-derived xenografts and organoids model therapy response in prostate cancer

por Karkampouna, Sofia, La Manna, Federico, Benjak, Andrej, Kiener, Mirjam, De Menna, Marta, Zoni, Eugenio, Grosjean, Joël, Klima, Irena, Garofoli, Andrea, Bolis, Marco, Vallerga, Arianna, Theurillat, Jean-Philippe, De Filippo, Maria R., Genitsch, Vera, Keller, David, Booij, Tijmen H., Stirnimann, Christian U., Eng, Kenneth, Sboner, Andrea, Ng, Charlotte K. Y., Piscuoglio, Salvatore, Gray, Peter C., Spahn, Martin, Rubin, Mark A., Thalmann, George N., Kruithof-de Julio, Marianna
Publicado 2021

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

por Bianco, Gaia, Coto-Llerena, Mairene, Gallon, John, Kancherla, Venkatesh, Taha-Mehlitz, Stephanie, Marinucci, Mattia, Konantz, Martina, Srivatsa, Sumana, Montazeri, Hesam, Panebianco, Federica, Tirunagaru, Vijaya G., De Menna, Marta, Paradiso, Viola, Ercan, Caner, Dahmani, Ahmed, Montaudon, Elodie, Beerenwinkel, Niko, Kruithof-de Julio, Marianna, Terracciano, Luigi M., Lengerke, Claudia, Jeselsohn, Rinath M., Doebele, Robert C., Bidard, François-Clément, Marangoni, Elisabetta, Ng, Charlotte K. Y., Piscuoglio, Salvatore
Publicado 2022

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

por Bianco, Gaia, Coto-Llerena, Mairene, Gallon, John, Kancherla, Venkatesh, Taha-Mehlitz, Stephanie, Marinucci, Mattia, Konantz, Martina, Srivatsa, Sumana, Montazeri, Hesam, Panebianco, Federica, Tirunagaru, Vijaya G., De Menna, Marta, Paradiso, Viola, Ercan, Caner, Dahmani, Ahmed, Montaudon, Elodie, Beerenwinkel, Niko, Kruithof-de Julio, Marianna, Terracciano, Luigi M., Lengerke, Claudia, Jeselsohn, Rinath M., Doebele, Robert C., Bidard, François-Clément, Marangoni, Elisabetta, Ng, Charlotte K. Y., Piscuoglio, Salvatore
Publicado 2022